In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 84102-69-2, name is Ethyl (5-bromobenzofuran)-2-carboxylate, introducing its new discovery. Formula: C11H9BrO3
The present invention relates to novel, non-secosteroidal, phenyl-benzofuran compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1alpha,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 84102-69-2, and how the biochemistry of the body works.Formula: C11H9BrO3
Reference:
Benzofuran – Wikipedia,
Benzofuran | C8H4033O – PubChem